Corporate Banner
Satellite Banner
Metabolomics & Lipidomics
Scientific Community
Become a Member | Sign in
Home>News>This Article

Researchers Identify Key Mechanism in Metabolic Pathway that Fuels Cancers

Published: Friday, May 23, 2014
Last Updated: Friday, May 23, 2014
Bookmark and Share
Discovery provides potential target for defeating hard-to-treat tumors.

In a discovery at the Children’s Medical Center Research Institute at UT Southwestern (CRI), a research team led by Ralph DeBerardinis, M.D., Ph.D., has taken a significant step in cracking the code of an atypical metabolic pathway that allows certain cancerous tumors to thrive, providing a possible roadmap for defeating such cancers.

Published in Cell Reports, and following up on Dr. DeBerardinis’ landmark finding in 2011, this most recent discovery identifies the triggering mechanism that plays a key role in causing a series of energy-generating chemical reactions known as the Krebs cycle to run in reverse.

“With this finding, we have learned there are particular enzymes that work together to enable the reverse pathway to function, much like the tiny gears that turn in opposite directions to power a mechanical clock,” said Dr. DeBerardinis, director of CRI’s Genetic and Metabolic Disease Program and associate professor in the Department of Pediatrics and the Eugene McDermott Center for Human Growth and Development at UT Southwestern Medical Center.

The identification of the mechanism could provide a future target for drugs that would attack tumors relying upon the reverse pathway for sustenance and growth.

Tumors of this type, often found in the brain, lungs and kidneys, tend to be difficult for oncologists to treat because cells using the atypical pathway seem to resist existing treatments like chemotherapy.

“Prior to this discovery, we didn’t have enough information about how to tap into the reverse metabolic pathway without disrupting the pathways that were operating in the typical, forward manner,” said Dr. DeBerardinis, senior author of the study. “We now believe there is a specific enzyme critical to the reverse pathway that can be deleted without impairing normal function. If we can eliminate that enzyme, we may be able to starve tumors of their supply of building blocks for growth.”

Further Information
Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 2,800+ scientific posters on ePosters
  • More than 4,000+ scientific videos on LabTube
  • 35 community eNewsletters

Sign In

Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

UT Southwestern’s Dr. Philipp Scherer Receive Banting Medal
Dr. Scherer will receive the prestigious Medal for diabetes research.
Friday, May 08, 2015
Scherer to Receive Banting Medal for Diabetes Research
Medal recognizes significant, long-term contributions to the understanding, treatment, or prevention of diabetes.
Thursday, April 30, 2015
UT Southwestern Researchers Uncover New Brain Pathways
New therapies for treating Type 2 diabetes and obesity.
Saturday, July 26, 2014
Inflammation in Fat Tissue Helps Prevent Metabolic Disease
The findings were first published online June 12 in Cell Metabolism.
Thursday, June 19, 2014
Researchers Identify Gene Tied to Extremely Rare Disorder that Causes Inflammation and Loss of Fat
UT Southwestern Medical Center researchers have identified a gene responsible for a rare disease that results in severe joint stiffness, muscle loss, anemia and panniculitis-induced lipodystrophy, or JMP syndrome.
Thursday, December 02, 2010
Circuit Regulating Anti-Diabetic Actions of Serotonin Uncovered By UT Southwestern Researchers
A brain chemical known to help regulate emotion, mood and sleep – might also have anti-diabetic properties, findings suggest.
Friday, November 12, 2010
UT Southwestern Researchers Discover Important Link Between Adrenal Gland Hormone and Brain in Hypertension
A hormone already responsible for increasing blood pressure appears as a major stimulator of the brain centers that control the vascular system.
Wednesday, November 10, 2010
Blood Test Could Diagnose Alzheimer’s Disease, UT Southwestern Researchers Find in Statewide Study
A set of proteins found in blood serum shows promise as a sensitive and accurate way to diagnose Alzheimer’s disease.
Thursday, October 07, 2010
Researchers Identify how Bone-Marrow Stem Cells Hold their 'Breath' in Low-Oxygen Environments
UT Southwestern researchers identify unique metabolic properties that allow specific stem cells to survive and replicate in low-oxygen environments.
Monday, September 06, 2010
Researchers Block Pathway that Performs Key Function in End-Stage Prostate Cancer Tumor Progression
UT Southwestern researchers find that blocking one of the enzymatic steps that allow the tumor to produce androgens could be the key in halting a tumor's growth.
Friday, July 23, 2010
Protein Must Exist in Specific Brain Cells to Prevent Diet-Induced Obesity, UT Southwestern Researchers Find
The protein named ‘longevity’ must be present in a specific set of neurons in the brain to prevent weight gain after chronic feeding on high-calorie meals.
Wednesday, July 07, 2010
New Brain Nerve Cells Key to Stress Resilience, UT Southwestern Researchers Find
Researchers have found new clues that might help explain why some people are more susceptible to stress than others.
Thursday, April 01, 2010
Gene Mutation is Linked to Autism-Like Symptoms in Mice, UT Southwestern Researchers Find
The study highlights the possibility that some autism-related behaviors can be reversed through drugs targeting specific brain function abnormalities.
Friday, February 26, 2010
Loss of Gene Function in Certain Prostate Cancer Cells Makes them More Aggressive
Eliminating the DAB2IP scaffolding in human carcinoma cells caused them to change from epithelial cells to mesenchymal cells, study finds.
Thursday, February 04, 2010
Experimental Drug Shows Promise Against Brain, Prostate Cancers, UT Southwestern Researchers Find
Study shows that drug attacked not only the bulk of the tumor cells but also the rare cancer stem cells responsible for cancer’s growth.
Wednesday, January 06, 2010
Scientific News
Gut Microbes Signal to the Brain When They're Full
Don't have room for dessert? The bacteria in your gut may be telling you something.
Turning up the Tap on Microbes Leads to Better Protein Patenting
Mining millions of proteins could become faster and easier with a new technique that may also transform the enzyme-catalyst industry, according to University of California, Davis, researchers.
Drug May Prevent Life-Threatening Muscle Loss in Advanced Cancers
New data describes how an experimental drug can stop life-threatening muscle wasting (cachexia) associated with advanced cancers and restore muscle health.
Cancer-Fighting Tomato Component Traced
The metabolic pathway associated with lycopene, the bioactive red pigment found in tomatoes, has been traced by researchers at the University of Illinois.
Circadian Clock Controls Insulin and Blood Sugar in Pancreas
Map of thousands of genes suggests new therapeutic targets for diabetes.
Cellular Stress Process Identified in Cardiovascular Disease
Combining the investigative tools of genetics, transcriptomics, epigenetics and metabolomics, a Duke Medicine research team has identified a new molecular pathway involved in heart attacks and death from heart disease.
Predicting Adverse Drug Reactions with Higher Confidence
A new integrated computational method helps predicting adverse drug reaction—which are often lethal—more reliably than with traditional computing methods.
A New Way to Starve Lung Cancer?
Metabolic alterations in lung cancer may open new avenues for treating the disease.
Evidence of How Incurable Cancer Develops
Researchers in the West Midlands have made a breakthrough in explaining how an incurable type of blood cancer develops from an often symptomless prior blood disorder.
Building a Better Liposome
Computational models suggest new design for nanoparticles used in targeted drug delivery.
Skyscraper Banner

SELECTBIO Market Reports
Go to LabTube
Go to eposters
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,800+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,000+ scientific videos